Pharmacovigilance and safety aspects of sevoflurane.
Publication
, Journal Article
Kharasch, ED
Published in: Acta Anaesthesiol Scand Suppl
1997
Duke Scholars
Published In
Acta Anaesthesiol Scand Suppl
ISSN
0515-2720
Publication Date
1997
Volume
111
Start / End Page
146 / 148
Location
England
Related Subject Headings
- United States Food and Drug Administration
- United States
- Sevoflurane
- Safety
- Product Surveillance, Postmarketing
- Methyl Ethers
- Kidney
- Hydrocarbons, Fluorinated
- Humans
- Heart
Citation
APA
Chicago
ICMJE
MLA
NLM
Kharasch, E. D. (1997). Pharmacovigilance and safety aspects of sevoflurane. Acta Anaesthesiol Scand Suppl, 111, 146–148.
Kharasch, E. D. “Pharmacovigilance and safety aspects of sevoflurane.” Acta Anaesthesiol Scand Suppl 111 (1997): 146–48.
Kharasch ED. Pharmacovigilance and safety aspects of sevoflurane. Acta Anaesthesiol Scand Suppl. 1997;111:146–8.
Kharasch, E. D. “Pharmacovigilance and safety aspects of sevoflurane.” Acta Anaesthesiol Scand Suppl, vol. 111, 1997, pp. 146–48.
Kharasch ED. Pharmacovigilance and safety aspects of sevoflurane. Acta Anaesthesiol Scand Suppl. 1997;111:146–148.
Published In
Acta Anaesthesiol Scand Suppl
ISSN
0515-2720
Publication Date
1997
Volume
111
Start / End Page
146 / 148
Location
England
Related Subject Headings
- United States Food and Drug Administration
- United States
- Sevoflurane
- Safety
- Product Surveillance, Postmarketing
- Methyl Ethers
- Kidney
- Hydrocarbons, Fluorinated
- Humans
- Heart